Access to anti-retroviral drugs, female in Yemen
Yemen: Access to anti-retroviral drugs, female was 34.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Yemen, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Yemen stood at 34.0%. That is the highest value across all 25 years on record.
That represents a change of up 3.0% on the previous year and up 88.9% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Yemen peaked at 34.0% in 2024 and was at its lowest, 0.0%, in 2000.
Yemen ranks 132nd of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Yemen, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 2.0% | — |
| 2008 | 4.0% | +100.0% |
| 2009 | 5.0% | +25.0% |
| 2010 | 9.0% | +80.0% |
| 2011 | 11.0% | +22.2% |
| 2012 | 12.0% | +9.1% |
| 2013 | 14.0% | +16.7% |
| 2014 | 18.0% | +28.6% |
| 2015 | 19.0% | +5.6% |
| 2016 | 23.0% | +21.1% |
| 2017 | 25.0% | +8.7% |
| 2018 | 26.0% | +4.0% |
| 2019 | 28.0% | +7.7% |
| 2020 | 29.0% | +3.6% |
| 2021 | 29.0% | +0.0% |
| 2022 | 31.0% | +6.9% |
| 2023 | 33.0% | +6.5% |
| 2024 | 34.0% | +3.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.1% | 0.0% | 5.0% | 10 |
| 2010s | 18.5% | 9.0% | 28.0% | 10 |
| 2020s | 31.2% | 29.0% | 34.0% | 5 |
Countries ranked near Yemen
More gender data for Yemen
- Child population (UN estimates and projections) 19,054 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.67 % change on previous year (2030)
- Population 28,613 (2030)
- Working-age population (UN estimates and projections) 28,613 (2030)
- Population (UN estimates and projections), annual growth rate 3.09 % change on previous year (2030)
- Age population, age 00, female, interpolated 662,464 (2025)
- Age population, age 00, male, interpolated 697,629 (2025)
- Age population, age 01, female, interpolated 655,085 (2025)
- Age population, age 01, male, interpolated 689,139 (2025)
- Age population, age 02, female, interpolated 643,105 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Yemen?
- Access to anti-retroviral drugs, female in Yemen was 34.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Yemen?
- The highest recorded value was 34.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Yemen?
- The lowest recorded value was 0.0% in 2000.
- How does Yemen rank for access to anti-retroviral drugs, female?
- Yemen ranks 132nd out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Yemen?
- Over the last ten years it is up 88.9%. The long-run trend across the full record is volatile.
- Where does this Yemen data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.